
Eric Olson
Examiner (ID: 3855, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1693, 1673 |
| Total Applications | 1706 |
| Issued Applications | 961 |
| Pending Applications | 123 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7111734
[patent_doc_number] => 20050209190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Camptothecin complexes'
[patent_app_type] => utility
[patent_app_number] => 11/008633
[patent_app_country] => US
[patent_app_date] => 2004-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8540
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209190.pdf
[firstpage_image] =>[orig_patent_app_number] => 11008633
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/008633 | Camptothecin complexes | Dec 7, 2004 | Abandoned |
Array
(
[id] => 53248
[patent_doc_number] => 07772207
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-10
[patent_title] => 'Combination of a CDK inhibitor and CS-682 or a metabolite thereof'
[patent_app_type] => utility
[patent_app_number] => 10/581585
[patent_app_country] => US
[patent_app_date] => 2004-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5713
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/772/07772207.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581585
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581585 | Combination of a CDK inhibitor and CS-682 or a metabolite thereof | Dec 2, 2004 | Issued |
Array
(
[id] => 7237862
[patent_doc_number] => 20050080041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Method and composition for the treatment of adenoviral ocular infections'
[patent_app_type] => utility
[patent_app_number] => 10/997955
[patent_app_country] => US
[patent_app_date] => 2004-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3199
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20050080041.pdf
[firstpage_image] =>[orig_patent_app_number] => 10997955
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/997955 | Method and composition for the treatment of adenoviral ocular infections | Nov 28, 2004 | Issued |
Array
(
[id] => 168606
[patent_doc_number] => 07666905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-23
[patent_title] => 'Compositions comprising hepoxilin analogs and their use in the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/999195
[patent_app_country] => US
[patent_app_date] => 2004-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 8234
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/666/07666905.pdf
[firstpage_image] =>[orig_patent_app_number] => 10999195
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/999195 | Compositions comprising hepoxilin analogs and their use in the treatment of cancer | Nov 28, 2004 | Issued |
Array
(
[id] => 7597631
[patent_doc_number] => 07618946
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-17
[patent_title] => 'Analgesic compounds, extracts containing same and methods of preparation'
[patent_app_type] => utility
[patent_app_number] => 10/580805
[patent_app_country] => US
[patent_app_date] => 2004-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 69
[patent_no_of_words] => 19690
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/618/07618946.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580805
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580805 | Analgesic compounds, extracts containing same and methods of preparation | Nov 25, 2004 | Issued |
Array
(
[id] => 833655
[patent_doc_number] => 07396946
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-08
[patent_title] => 'Compound for treatment of external secretion disorders'
[patent_app_type] => utility
[patent_app_number] => 10/994364
[patent_app_country] => US
[patent_app_date] => 2004-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9094
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/396/07396946.pdf
[firstpage_image] =>[orig_patent_app_number] => 10994364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/994364 | Compound for treatment of external secretion disorders | Nov 22, 2004 | Issued |
Array
(
[id] => 6959559
[patent_doc_number] => 20050215568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Substituted oxetanes, method of making, and method of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/992805
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11723
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215568.pdf
[firstpage_image] =>[orig_patent_app_number] => 10992805
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/992805 | Substituted oxetanes, method of making, and method of use thereof | Nov 18, 2004 | Issued |
Array
(
[id] => 7111729
[patent_doc_number] => 20050209185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases'
[patent_app_type] => utility
[patent_app_number] => 10/994030
[patent_app_country] => US
[patent_app_date] => 2004-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34199
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209185.pdf
[firstpage_image] =>[orig_patent_app_number] => 10994030
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/994030 | Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases | Nov 17, 2004 | Abandoned |
Array
(
[id] => 7046135
[patent_doc_number] => 20050250730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases'
[patent_app_type] => utility
[patent_app_number] => 10/991634
[patent_app_country] => US
[patent_app_date] => 2004-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34198
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250730.pdf
[firstpage_image] =>[orig_patent_app_number] => 10991634
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/991634 | Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases | Nov 17, 2004 | Abandoned |
Array
(
[id] => 7249877
[patent_doc_number] => 20050142087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Compositions containing silicone-in-water emulsions, salts, alcohols and solvents'
[patent_app_type] => utility
[patent_app_number] => 10/989847
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6695
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20050142087.pdf
[firstpage_image] =>[orig_patent_app_number] => 10989847
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/989847 | Compositions containing silicone-in-water emulsions, salts, alcohols and solvents | Nov 11, 2004 | Abandoned |
Array
(
[id] => 5252731
[patent_doc_number] => 20070134187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders'
[patent_app_type] => utility
[patent_app_number] => 10/577444
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5904
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134187.pdf
[firstpage_image] =>[orig_patent_app_number] => 10577444
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/577444 | Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders | Oct 28, 2004 | Issued |
Array
(
[id] => 7011405
[patent_doc_number] => 20050065121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Methods to increase plasma HDL cholesterol levels and improve HDL functionality with probucol monoesters'
[patent_app_type] => utility
[patent_app_number] => 10/977752
[patent_app_country] => US
[patent_app_date] => 2004-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 29453
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20050065121.pdf
[firstpage_image] =>[orig_patent_app_number] => 10977752
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/977752 | Methods to increase plasma HDL cholesterol levels and improve HDL functionality with probucol monoesters | Oct 28, 2004 | Abandoned |
Array
(
[id] => 5080265
[patent_doc_number] => 20070123489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (HIT) syndrome'
[patent_app_type] => utility
[patent_app_number] => 10/974566
[patent_app_country] => US
[patent_app_date] => 2004-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 17873
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20070123489.pdf
[firstpage_image] =>[orig_patent_app_number] => 10974566
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/974566 | Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (HIT) syndrome | Oct 26, 2004 | Issued |
Array
(
[id] => 6966092
[patent_doc_number] => 20050232989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Process for preparing oral calcium compositions'
[patent_app_type] => utility
[patent_app_number] => 10/973352
[patent_app_country] => US
[patent_app_date] => 2004-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5971
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20050232989.pdf
[firstpage_image] =>[orig_patent_app_number] => 10973352
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/973352 | Process for preparing oral calcium compositions | Oct 26, 2004 | Abandoned |
Array
(
[id] => 7257687
[patent_doc_number] => 20050143573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Reduced malto-oligosaccharides'
[patent_app_type] => utility
[patent_app_number] => 10/963681
[patent_app_country] => US
[patent_app_date] => 2004-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5468
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20050143573.pdf
[firstpage_image] =>[orig_patent_app_number] => 10963681
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/963681 | Reduced malto-oligosaccharides | Oct 12, 2004 | Issued |
Array
(
[id] => 435923
[patent_doc_number] => 07262180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-28
[patent_title] => 'Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye'
[patent_app_type] => utility
[patent_app_number] => 10/963848
[patent_app_country] => US
[patent_app_date] => 2004-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7994
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/262/07262180.pdf
[firstpage_image] =>[orig_patent_app_number] => 10963848
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/963848 | Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye | Oct 11, 2004 | Issued |
Array
(
[id] => 5259749
[patent_doc_number] => 20070213381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Topical Compositions Comprising Telmesteine for Treating Dermatological Disorders'
[patent_app_type] => utility
[patent_app_number] => 10/575023
[patent_app_country] => US
[patent_app_date] => 2004-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4415
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20070213381.pdf
[firstpage_image] =>[orig_patent_app_number] => 10575023
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/575023 | Topical Compositions Comprising Telmesteine for Treating Dermatological Disorders | Oct 6, 2004 | Abandoned |
Array
(
[id] => 7110533
[patent_doc_number] => 20050207988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Polysaccharides for pulmonary delivery of active agents'
[patent_app_type] => utility
[patent_app_number] => 10/957218
[patent_app_country] => US
[patent_app_date] => 2004-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26814
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20050207988.pdf
[firstpage_image] =>[orig_patent_app_number] => 10957218
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/957218 | Polysaccharides for pulmonary delivery of active agents | Sep 30, 2004 | Issued |
Array
(
[id] => 6939740
[patent_doc_number] => 20050113303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Use of PEX in the treatment of metabolic bone diseases'
[patent_app_type] => utility
[patent_app_number] => 10/952878
[patent_app_country] => US
[patent_app_date] => 2004-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 13958
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113303.pdf
[firstpage_image] =>[orig_patent_app_number] => 10952878
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/952878 | Inhibition of PEX in the treatment of metabolic bone diseases | Sep 29, 2004 | Issued |
Array
(
[id] => 6918773
[patent_doc_number] => 20050096334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Use of substance P antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of NK-1 receptor antagonists for the treatment of chronic fatigue syndrome'
[patent_app_type] => utility
[patent_app_number] => 10/947967
[patent_app_country] => US
[patent_app_date] => 2004-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4092
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20050096334.pdf
[firstpage_image] =>[orig_patent_app_number] => 10947967
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/947967 | Use of substance P antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of NK-1 receptor antagonists for the treatment of chronic fatigue syndrome | Sep 22, 2004 | Abandoned |